The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of BCD-021, bevacizumab biosimilar candidate, compared to Avastin: Results of international multicenter randomized double blind phase III study in patients with advanced non-squamous NSCLC.
 
Olga Filon
No Relationships to Disclose
 
Sergey Orlov
No Relationships to Disclose
 
Olga Burdaeva
No Relationships to Disclose
 
Mikhail V. Kopp
No Relationships to Disclose
 
Bogdan Kotiv
No Relationships to Disclose
 
Sergiy Alekseev
No Relationships to Disclose
 
Aleksandr Pecheniy
No Relationships to Disclose
 
Daniil Stroyakovskiy
No Relationships to Disclose
 
Oleg Gladkov
No Relationships to Disclose
 
Andrey Khorinko
No Relationships to Disclose
 
Marina Matrosova
No Relationships to Disclose
 
Rinat Galiulin
No Relationships to Disclose
 
Pavel Skopin
No Relationships to Disclose
 
Guzel Mukhametsina
No Relationships to Disclose
 
Sergey Odarchenko
No Relationships to Disclose
 
Sergey Kulik
No Relationships to Disclose
 
Jaroslav Kulyaba
No Relationships to Disclose
 
Grigory Adamchuk
No Relationships to Disclose
 
Yurii Vinnyk
No Relationships to Disclose
 
Sergei Tjulandin
Speakers' Bureau - AstraZeneca; Eisai; Pfizer; Sanofi
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Boehringer Ingelheim; Merck Serono